Traditional Chinese medicine composition for treating myocardial ischemia and application thereof

Through the effects of traditional Chinese medicine compositions to promote blood circulation, remove blood stasis, regulate qi and unclog the meridians, nourish blood and calm the mind, the existing problems of poor efficacy in treating myocardial ischemia are solved, significantly improving myocardial blood supply, heart valve regurgitation and ascending aortic aneurysm. Increase cardiac output.

CN118924853APending Publication Date: 2024-11-12刘尊基
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411104877.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing drugs for treating myocardial ischemia have limited effects in some patients, especially in the treatment of heart valve regurgitation and ascending aortic aneurysms.

Method used

A Chinese medicine composition is adopted, including angelica, raw rehmannia, peach kernel, safflower, raw malt, fried citrus aurantium, red peony, Bupleurum, raw licorice, platycodon, Chuanxiong, Chuanxiong, fried jujube kernel, night-history vine, cinnamon Branches and roasted licorice are made according to the principles of blood circulation, blood circulation, stasis, liver stasis, qi, nourish yin and blood. They have the effects of promoting blood circulation, stasis, regulating qi and unblocking meridians, nourishing blood and calming the mind.

Benefits of technology

It significantly relieves symptoms such as fatigue, chest tightness, palpitations, insomnia and irritability, improves myocardial blood supply, reduces heart valve regurgitation and ascending aortic aneurysm-like dilation, improves cardiac output, and enhances myocardial hypoxia resistance.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to a traditional Chinese medicine composition for treating myocardial ischemia and application thereof. The traditional Chinese medicine composition is prepared from the following raw materials: angelica sinensis, radix rehmanniae, peach kernel, safflower carthamus, raw malt, fried fructus aurantii, radix paeoniae rubra, radix bupleuri, raw liquorice, platycodon grandiflorum, ligusticum wallichii, radix cyathulae, fried jujube kernel, tuber fleeceflower stem, cassia twig and honey-fried liquorice. The traditional Chinese medicine composition disclosed by the invention has the effects of promoting blood circulation to remove blood stasis, regulating qi and dredging collaterals, and nourishing blood and tranquilizing, can obviously relieve symptoms such as weakness, chest distress and chest pain, palpitation and palpitation, insomnia and dysphoria and the like, and can obviously improve myocardial blood supply, reduce heart valve regurgitation and treat ascending aortic aneurysm.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of traditional Chinese medicines, and relates to a traditional Chinese medicine composition for treating myocardial ischemia and application thereof. Background Art

[0002] There are 290 million cardiovascular diseases in China, of which ischemic heart disease accounts for about 36.87%, and the mortality rate ranks first. Ischemic heart disease is caused by partial or complete occlusion of coronary arteries, myocardial tissue ischemia, leading to cardiac function damage, clinical symptoms such as chest tightness, chest pain, fatigue, insomnia, back fatigue, limb numbness, irritability, constipation, etc. The longer this situation lasts, the more serious the damage to the heart, so it is crucial to take treatment measures as soon as possible. According to traditional Chinese medicine theory, heart meridian blockage is the main pathogenesis of the disease, cold evil invasion, qi deficiency and spleen and kidney yang deficiency are the fundamental causes, and invigorating qi and activating blood circulation, promoting qi and removing blood stasis, resolving phlegm and unblocking collaterals, warming yang and unblocking meridians, invigorating qi and nourishing yin, and supporting yang and consolidating torsion are the basic treatments for the disease. At present, therapeutic drugs have a certain effect on myocardial ischemia, but in clinical practice, there are still a certain number of patients who fail to significantly relieve clinical symptoms after using Chinese patent medicines, and there is no clear report on the therapeutic effect on heart valve regurgitation and ascending aortic aneurysm. Summary of the invention

[0003] In view of the deficiencies of the prior art, the object of the present invention is to provide a Chinese medicine composition for treating myocardial ischemia and its application.

[0004] In order to achieve the purpose of the invention, the present invention adopts the following technical solutions:

[0005] In a first aspect, the present invention provides a traditional Chinese medicine composition for treating myocardial ischemia, wherein the raw materials for preparing the traditional Chinese medicine composition include angelica, raw rehmannia, peach kernel, safflower, raw malt, stir-fried fructus aurantii, red peony root, bupleurum, raw licorice, platycodon, ligusticum chuanxiong, cyathula, stir-fried jujube kernel, polyphylla, cassia twig, and roasted licorice.

[0006] The Chinese medicine composition described in the present application summarizes a large number of clinical cases and is prepared according to the prescription principles of promoting blood circulation and removing blood stasis, soothing the liver and regulating qi, and nourishing yin and blood. The Chinese medicine composition is a pure Chinese medicine preparation, which has the effects of promoting blood circulation and removing blood stasis, regulating qi and unblocking collaterals, nourishing blood and calming the mind, can significantly relieve symptoms such as fatigue, chest tightness and pain, palpitations, insomnia and irritability, can significantly improve myocardial blood supply, and reduce heart valve regurgitation and ascending aortic aneurysm-like dilatation.

[0007] Preferably, the raw materials for preparing the traditional Chinese medicine composition include, by mass, 8-12 parts of angelica sinensis, 8-12 parts of raw rehmannia, 10-14 parts of peach kernel, 8-12 parts of safflower, 5-8 parts of raw malt, 5-8 parts of stir-fried fructus aurantii, 5-8 parts of red peony root, 1-4 parts of bupleurum, 1-4 parts of raw licorice, 3-6 parts of platycodon, 3-6 parts of chuanxiong, 8-12 parts of cyathula, 8-12 parts of stir-fried jujube kernel, 8-12 parts of polyphylla, 0.1-0.4 parts of cassia twig, and 1-4 parts of roasted licorice.

[0008] The mass portions of the angelica sinensis can be selected from 8 parts, 8.2 parts, 8.5 parts, 8.8 parts, 9 parts, 9.2 parts, 9.5 parts, 9.8 parts, 10 parts, 10.2 parts, 10.5 parts, 10.8 parts, 11 parts, 11.2 parts, 11.5 parts, 11.8 parts, 12 parts, etc.; the mass portions of the rehmannia glutinosa can be selected from 8 parts, 8.2 parts, 8.5 parts, 8.8 parts, 9 parts, 9.2 parts, 9.5 parts, 9.8 parts, 10 parts, 10.2 parts, 10.5 parts, 10.8 parts, 11 parts, 11.2 parts, 11.5 parts, 11.8 parts, 12 parts, etc.; the mass portions of the peach kernel can be selected from 10 parts, 10.2 parts, 10.5 parts, 10.8 parts, 11 parts, 11.2 parts, 11.5 parts, 11.8 parts, The weight of safflower can be 8 parts, 8.2 parts, 8.5 parts, 8.8 parts, 9 parts, 9.2 parts, 9.5 parts, 9.8 parts, 10 parts, 10.2 parts, 10.5 parts, 10.8 parts, 11 parts, 11.2 parts, 11.5 parts, 11.8 parts, 12 parts, etc. The weight of raw malt can be 5 parts, 5.2 parts, 5.5 parts, 5.8 parts, 6 parts, 6.2 parts, 6.5 parts, 6.8 parts, 7 parts, 7.2 parts, 7.5 parts, 7.8 parts, 8 parts, etc. The weight of stir-fried Citrus aurantium can be 5 parts, 5.2 parts, 5.5 parts, 5.8 parts, 6 parts, 6. The mass portions of Radix Paeoniae Rubra can be selected from 5 parts, 5.2 parts, 5.5 parts, 5.8 parts, 6 parts, 6.2 parts, 6.5 parts, 6.8 parts, 7 parts, 7.2 parts, 7.5 parts, 7.8 parts, 8 parts, etc. The mass portions of Radix Bupleuri can be selected from 1 part, 1.2 parts, 1.5 parts, 1.8 parts, 2 parts, 2.2 parts, 2.5 parts, 2.8 parts, 3 parts, 3.2 parts, 3.5 parts, 3.8 parts, 4 parts, etc. The mass portions of Radix Licorice can be selected from 1 part, 1.2 parts, 1.5 parts, 1.8 parts, 2 parts, 2.2 parts, 2.5 parts, 2.8 parts, 3 parts, 3.2 parts, 3.5 parts, 3.8 parts, 4 parts, etc. The mass portions of Radix Platycodonis can be selected from 1 part, 1.2 parts, 1.5 parts, 1.8 parts, 2 parts, 2.2 parts, 2.5 parts, 2.8 parts, 3 parts, 3.2 parts, 3.5 parts, 3.8 parts, 4 parts, etc. You can choose 3 parts, 3.2 parts, 3.5 parts, 3.8 parts, 4 parts, 4.2 parts, 4.5 parts, 4.8 parts, 5 parts, 5.2 parts, 5.5 parts, 5.8 parts, 6 parts, etc. The mass portions of Chuanxiong can be selected from 3 parts, 3.2 parts, 3.5 parts, 3.8 parts, 4 parts, 4.2 parts, 4.5 parts, 4.8 parts, 5 parts, 5.2 parts, 5.5 parts, 5.8 parts, 6 parts, etc. The mass portions of Sichuan Cyathula can be selected from 8 parts, 8.2 parts, 8.5 parts, 8.8 parts, 9 parts, 9.2 parts, 9.5 parts, 9.8 parts, 10 parts, 10.2 parts, 10.5 parts, 10.8 parts, 11 parts, 11.2 parts, 11.5 parts, 11.8 parts, 12 parts, etc. The mass portions of stir-fried jujube kernels can be selected from 8 parts, 8.2 parts, 8.5 parts, 8.8 parts, 9 parts, 9.2 parts, 9.5 parts, 9.8 parts, 10 parts, 10.2 parts, 10.5 parts, 10.8 parts, 11 parts, 11.2 parts, 11.5 parts, 11.8 parts, 12 parts, etc. The mass proportions of Polygonum multiflorum can be selected as 8 parts, 8.2 parts, 8.5 parts, 8.8 parts, 9 parts, 9.2 parts, 9.5 parts, 9.8 parts, 10 parts, 10.2 parts, 10.5 parts, 10.8 parts, 11 parts, 11.2 parts, 11.5 parts , 11.8 parts, 12 parts, etc., the mass fraction of cinnamon twig can be 0.1 parts, 0.15 parts, 0.2 parts, 0.25 parts, 0.3 parts, 0.35 parts, 0.4 parts, etc., the mass fraction of licorice can be 1 parts, 1.2 parts, 1.5 parts, 1.8 parts, 2 parts, 2.2 parts, 2.5 parts, 2.8 parts, 3 parts, 3.2 parts, 3.5 parts, 3.8 parts, 4 parts, etc., other specific point values ​​within the above numerical range can be selected, and they will not be repeated here. .

[0009] Preferably, the Chinese medicine composition is prepared by a method comprising the following steps: mixing and crushing the preparation raw materials.

[0010] In a second aspect, the present invention provides a use of the Chinese medicine composition for treating myocardial ischemia according to the first aspect in the preparation of a drug for improving cardiac output.

[0011] In a third aspect, the present invention provides a use of the Chinese medicine composition for treating myocardial ischemia according to the first aspect in the preparation of a medicament for reducing aortic valve area.

[0012] In a fourth aspect, the present invention provides a use of the traditional Chinese medicine composition for treating myocardial ischemia according to the first aspect in the preparation of a medicament for treating myocardial ischemia.

[0013] In a fifth aspect, the present invention provides a use of the Chinese medicine composition for treating myocardial ischemia according to the first aspect in the preparation of a medicament for treating heart valve regurgitation.

[0014] In a sixth aspect, the present invention provides a use of the traditional Chinese medicine composition for treating myocardial ischemia according to the first aspect in the preparation of a medicament for treating ascending aortic aneurysm.

[0015] Preferably, the dosage form of the drug includes tablets, pills, capsules, granules, granules, and oral liquids.

[0016] Preferably, the drug further comprises a pharmaceutically acceptable excipient.

[0017] Preferably, the auxiliary material comprises any one of an excipient, a diluent, a carrier, a flavoring agent, a binder or a filler, or a combination of at least two thereof.

[0018] Compared with the prior art, the present invention has the following beneficial effects:

[0019] The Chinese medicine composition of the present invention has the effects of promoting blood circulation and removing blood stasis, regulating qi and unblocking collaterals, nourishing blood and calming the mind, can significantly alleviate symptoms such as fatigue, chest tightness and pain, palpitations, insomnia and irritability, can significantly improve myocardial blood supply, treat ascending aortic aneurysm, and reduce heart valve regurgitation. DETAILED DESCRIPTION

[0020] The technical solution of the present invention is further described below by specific implementation methods. It should be understood by those skilled in the art that the embodiments are only to help understand the present invention and should not be regarded as specific limitations of the present invention.

[0021] Example 1

[0022] The present embodiment provides a traditional Chinese medicine composition for treating myocardial ischemia. The raw materials for preparing the traditional Chinese medicine composition include, by mass, 9 parts of angelica sinensis, 9 parts of raw rehmannia, 12 parts of peach kernel, 9 parts of safflower, 6 parts of raw malt, 6 parts of stir-fried fructus aurantii, 6 parts of red peony root, 3 parts of bupleurum, 3 parts of raw licorice, 4.5 parts of platycodon, 4.5 parts of ligusticum chuanxiong, 9 parts of cyathula, 9 parts of stir-fried jujube kernel, 9 parts of polyphylla polyphylla, 0.1 parts of cassia twig, and 3 parts of roasted licorice.

[0023] Its preparation method is:

[0024] The prepared raw materials are dried and crushed into fine powder, and sieved to obtain the product.

[0025] Example 2

[0026] The present embodiment provides a traditional Chinese medicine composition for treating myocardial ischemia. The raw materials for preparing the traditional Chinese medicine composition include, by mass, 8 parts of angelica sinensis, 12 parts of raw rehmannia, 10 parts of peach kernel, 8 parts of safflower, 5 parts of raw malt, 8 parts of stir-fried fructus aurantii, 8 parts of red peony root, 1 part of bupleurum, 4 parts of raw licorice, 6 parts of platycodon, 6 parts of chuanxiong, 8 parts of cyathula, 12 parts of stir-fried jujube kernel, 8 parts of polyphylla, 0.4 parts of cassia twig, and 4 parts of roasted licorice.

[0027] The preparation method is similar to that of Example 1.

[0028] Example 3

[0029] The present embodiment provides a traditional Chinese medicine composition for treating myocardial ischemia. The raw materials for preparing the traditional Chinese medicine composition include, by mass, 12 parts of angelica sinensis, 8 parts of raw rehmannia, 14 parts of peach kernel, 12 parts of safflower, 8 parts of raw malt, 5 parts of stir-fried fructus aurantii, 5 parts of red peony root, 4 parts of bupleurum, 1 part of raw licorice, 3 parts of platycodon, 3 parts of chuanxiong, 12 parts of cyathula, 8 parts of stir-fried jujube kernel, 12 parts of polyphylla, 0.2 parts of cassia twig, and 1 part of roasted licorice.

[0030] The preparation method is similar to that of Example 1.

[0031] Comparative Example 1

[0032] This comparative example provides a Chinese medicine composition for treating myocardial ischemia, which differs from Example 1 only in that raw malt is not included in the preparation raw materials, and its reduced mass is proportionally distributed to the mass of fried jujube seeds, polyphylla, cassia twig, and roasted liquorice, while other ingredients and contents remain unchanged.

[0033] The preparation method is similar to that of Example 1.

[0034] Comparative Example 2

[0035] This comparative example provides a Chinese medicine composition for treating myocardial ischemia, which differs from Example 1 only in that the preparation raw materials do not contain fried jujube seeds, and the reduced mass is proportionally distributed to the mass of raw malt, polyphylla, cassia twig, and roasted licorice, while the other ingredients and contents remain unchanged.

[0036] The preparation method is similar to that of Example 1.

[0037] Comparative Example 3

[0038] This comparative example provides a Chinese medicine composition for treating myocardial ischemia, which differs from Example 1 only in that the preparation raw materials do not contain Polygonum multiflorum, and its reduced mass is proportionally distributed to the mass of raw malt, fried jujube seeds, cassia twig, and roasted liquorice, while other ingredients and contents remain unchanged.

[0039] The preparation method is similar to that of Example 1.

[0040] Comparative Example 4

[0041] This comparative example provides a Chinese medicine composition for treating myocardial ischemia, which differs from Example 1 only in that cinnamon twig is not included in the preparation raw materials, and its reduced mass is proportionally distributed to the mass of raw malt, fried jujube seeds, polyphylla, and roasted liquorice, while other ingredients and contents remain unchanged.

[0042] The preparation method is similar to that of Example 1.

[0043] Comparative Example 5

[0044] This comparative example provides a traditional Chinese medicine composition for treating myocardial ischemia, which differs from Example 1 only in that the preparation raw materials do not contain roasted licorice, and its reduced mass is proportionally distributed to the mass of raw malt, fried jujube seeds, polyphylla, and cassia twig, while other ingredients and contents remain unchanged.

[0045] The preparation method is similar to that of Example 1.

[0046] Comparative Example 6

[0047] This comparative example provides a traditional Chinese medicine composition for treating myocardial ischemia, which is different from Example 1 only in that the preparation raw materials do not contain raw malt, fried jujube seeds, Polygonum multiflorum, cassia twig, and roasted liquorice, and the other ingredients and contents remain unchanged.

[0048] The preparation method is similar to that of Example 1.

[0049] Test Example 1

[0050] Grouping, modeling and drug administration of mice:

[0051] The experimental animals were 144 SPF Kunming mice, both male and female, weighing 18-20 g.

[0052] The mice were randomly divided into: a normal group, a model group, a positive drug (propranolol hydrochloride) group, and a sample group, wherein the sample group included Example 1-3 groups and Comparative Example 1-6 groups, with 12 mice in each group.

[0053] The normal group and the model group were gavaged with distilled water 20mL / kg, the positive drug group was administered with propranolol hydrochloride 33mg / kg, and the administration was continued for 7 days, and the sample groups were administered with samples of Examples 1-3 and Comparative Examples 1-6, respectively, with a dosage of 4g / kg, and the mice in each group were fed with ordinary feed and had free access to water. Starting from the 5th day, except for the normal group, the mice in the other groups were subcutaneously injected with ISO 20mg / kg 1h after administration, and the injection was continued for 3 days to prepare the myocardial ischemia model, and the mice in the normal group were subcutaneously injected with an equal dose of normal saline.

[0054] 1. Test of hypoxia tolerance:

[0055] Six mice were randomly selected from each group and placed in a 250 mL ground-mouth wide-mouth bottle containing 10 g of soda lime 30 minutes after the last subcutaneous injection of ISO. The mice were immediately timed and the survival time of the mice was observed based on the cessation of breathing. The results are shown in Table 1.

[0056] Table 1

[0057] Group Survival time (min) Example 1 33.56±1.63 Example 2 32.86±2.12 Example 3 32.41±1.55 Comparative Example 1 23.88±0.65 Comparative Example 2 22.73±0.88 Comparative Example 3 24.61±1.65 Comparative Example 4 21.66±1.52 Comparative Example 5 19.49±1.43 Comparative Example 6 19.03±1.09 Normal group 38.5±1.12 Model Group 17.52±2.15 Positive Drug 35.29±1.85

[0058] Myocardial ischemia is a complex disease with multiple causes. It is a pathological state in which the heart cannot work normally due to the reduction of blood supply and oxygen supply to the heart, which causes abnormal myocardial energy metabolism. Compared with the normal group, the survival time of mice in the model group was significantly shortened, indicating that the model was successful; compared with the model group, the survival time of mice in the positive drug group was significantly prolonged, indicating that the Chinese medicine composition of the present invention can improve the hypoxia tolerance of mice with myocardial ischemia, and the addition of raw malt, fried jujube seeds, Polygonum multiflorum, cinnamon twigs, and roasted licorice is conducive to improving the therapeutic effect of the Chinese medicine composition on myocardial ischemia, and there is potential mutual cooperation between the several Chinese medicines.

[0059] 2. Serum enzyme testing

[0060] Six mice were randomly selected from each group. The eyeballs were removed and blood was collected 30 minutes after the last subcutaneous injection of ISO. The blood was kept at room temperature for 2 hours and centrifuged at 3500 rpm for 15 minutes to separate the serum for the determination of SOD, MDA, and LDH. The SOD kit, MDA kit, and LDH kit were all purchased from Nanjing Jiancheng Bioengineering Institute.

[0061] Table 2

[0062] Group SOD(U / mL) LDH(U / L) MDA (nmoL / mL) Example 1 105.52±12.52 4120±228.65 4.18±0.76 Example 2 103.15±15.65 4256±165.54 4.29±0.65 Example 3 101.21±10.98 4298±129.96 4.59±0.83 Comparative Example 1 92.56±11.88 4656±345.81 5.22±0.56 Comparative Example 2 96.68±12.54 4721±261.23 5.35±0.72 Comparative Example 3 95.65±11.98 4652.84±45.21 5.52±1.85 Comparative Example 4 94.65±15.32 4859.23±325.65 5.65±1.22 Comparative Example 5 92.56±12.63 4932.32±481.63 5.88±0.95 Comparative Example 6 86.56±12.51 5286.65±521.22 6.10±1.27 Normal group 112.87±8.56 3986.89±367.82 3.85±0.66 Model Group 83.54±4.92 5521.67±672.31 6.89±1.25 Positive Drug 108.56±5.87 4055.95±204.13 4.15±0.85

[0063] SOD is a superoxide dismutase, which can remove oxygen free radicals in the body. Its level can indirectly reflect the body's ability to remove oxygen free radicals and the free radical content in the body. A decrease in the level may indicate a weakened antioxidant defense ability, which is related to myocardial ischemia-reperfusion injury. LDH is lactate dehydrogenase, and its increased level is usually related to tissue damage or cell necrosis. When myocardial cells rupture and necrotize, LDH is released into the blood, causing its value to increase. An increase in MDA levels is usually related to increased oxidative stress. Testing the amount of malondialdehyde can reflect the degree of lipid peroxidation in the body, which indirectly reflects the degree of cell damage.

[0064] The Chinese medicine composition of the present invention can improve the activity of SOD, protect myocardial cells, improve the stability of cell membranes, reduce the activity of lipid peroxide MDA, reduce the damage of oxygen free radicals to myocardium, protect ischemic myocardium, and treat ischemic heart disease. The addition of raw malt, fried jujube seeds, radix polyphyllae, cassia twig, and roasted liquorice root is conducive to improving the therapeutic effect of the Chinese medicine composition on myocardial ischemia, and there is potential mutual cooperation between the several Chinese medicines.

[0065] Test Example 2

[0066] Clinical testing

[0067] Patient condition: In the past 3 years, he suffered from recurrent palpitations and shortness of breath, difficulty falling asleep, frequent dreams and easy awakening. 3 days ago, the palpitations worsened, he was gasping for breath when moving, had a dizzy head, dry mouth, sore throat, red tip of tongue with white greasy coating, the left pulse was deep, stringy and astringent, and the right pulse was thin, astringent and tight. He was diagnosed with palpitations, qi stagnation and blood stasis.

[0068] Dosage: The patient takes the Chinese medicine composition described in Example 1 three times a day, 9 g each time, half an hour after a meal.

[0069] The next day after taking the medicine, the palpitations and shortness of breath were relieved, the dizziness was relieved, the sleep was improved, but I still had many dreams, the awakening time was shortened, and the dryness of the mouth was relieved.

[0070] After taking the medicine for one month, the symptoms were completely eliminated.

[0071] At the beginning of treatment and after taking 40 doses of the drug, the patients underwent cardiac B-ultrasound examinations, and the results are shown in Table 3.

[0072] Table 3

[0073] Before taking medication After taking the medicine Aortic regurgitation length 6.4cm 1.8cm Aortic regurgitation area <![CDATA[5.6cm 2 ]]> <![CDATA[2.1cm 2 ]]> Diastolic aortic valve clearance 1.5mm 0 Heart rate 58 times / min 76 times / min Cardiac output 4.6L / M 5.4L / M

[0074] From the results in Table 3, it can be seen that the Chinese medicine composition of the present invention can improve bradycardia, reduce the length of aortic valve regurgitation, reduce the area of ​​aortic valve regurgitation, and increase cardiac output, indicating that the Chinese medicine composition of the present application has the effect of alleviating and treating myocardial damage.

[0075] Test Example 3

[0076] Patient's condition: Male, 49 years old, had left chest tightness and pain in the left hypochondrium for 1 year. Left chest tightness and pain during work, accompanied by palpitations and back pain, normal appetite and sleep, and normal bowel movements. Repeated hospitalizations diagnosed with ascending aortic aneurysm, and surgical treatment was recommended. Cardiac B-ultrasound showed: the inner diameter of the ascending aortic aneurysm dilation was about 46mm.

[0077] Dosage: The patient takes the Chinese medicine composition described in Example 1 three times a day, 9 g each time, half an hour after a meal.

[0078] After taking the medicine for 3 days, the tightness and pain in the left chest and the pain in the left hypochondrium were significantly relieved, and the symptoms were completely eliminated after 50 doses.

[0079] During the treatment, the patient underwent cardiac B-ultrasound examinations several times, and the results are shown in Table 4.

[0080] Table 4

[0081] Cardiac B-ultrasound examination time Anomalous Items 2005.5.17 Ascending aortic aneurysm dilatation inner diameter 46mm 2005.6.27 Ascending aortic aneurysm dilatation inner diameter 45mm 2005.10.1 Ascending aortic aneurysm dilatation inner diameter 38mm 2006.9.21 No obvious abnormality was found in the cardiac structure

[0082] It can be seen from the data in Table 4 that the Chinese medicine composition described in the present application can eliminate aneurysmal dilatation of the ascending aorta and can be used in drugs for treating the disease.

[0083] The applicant declares that the present invention illustrates a Chinese medicine composition for treating myocardial ischemia and its application through the above-mentioned embodiments, but the present invention is not limited to the above-mentioned embodiments, that is, it does not mean that the present invention must rely on the above-mentioned embodiments to be implemented. Those skilled in the art should understand that any improvement of the present invention, equivalent replacement of various raw materials of the product of the present invention, addition of auxiliary components, selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.

[0084] The preferred embodiments of the present invention are described in detail above. However, the present invention is not limited to the specific details in the above embodiments. Within the technical concept of the present invention, a variety of simple modifications can be made to the technical solution of the present invention, and these simple modifications all belong to the protection scope of the present invention.

[0085] It should also be noted that the various specific technical features described in the above specific embodiments can be combined in any suitable manner without contradiction. In order to avoid unnecessary repetition, the present invention will not further describe various possible combinations.

Claims

1. A Chinese medicine composition for treating myocardial ischemia, It is characterized in that The raw materials for preparing the traditional Chinese medicine composition include angelica, raw rehmannia, peach kernel, safflower, raw malt, fried fructus aurantii, red peony root, bupleurum, raw licorice, platycodon, ligusticum chuanxiong, cyathula, fried jujube kernel, polyphylla polyphylla, cassia twig and roasted licorice.

2. The Chinese medicine composition for treating myocardial ischemia according to claim 1, It is characterized in that The raw materials for preparing the traditional Chinese medicine composition include, by weight, 8-12 parts of angelica sinensis, 8-12 parts of raw rehmannia, 10-14 parts of peach kernel, 8-12 parts of safflower, 5-8 parts of raw malt, 5-8 parts of stir-fried fructus aurantii, 5-8 parts of red peony root, 1-4 parts of bupleurum, 1-4 parts of raw licorice, 3-6 parts of platycodon, 3-6 parts of ligusticum chuanxiong, 8-12 parts of cyathula, 8-12 parts of stir-fried jujube kernel, 8-12 parts of polyphylla polyphylla, 0.1-0.4 parts of cassia twig, and 1-4 parts of roasted licorice.

3. The Chinese medicine composition for treating myocardial ischemia according to claim 1 or 2, It is characterized in that The traditional Chinese medicine composition is prepared by a method comprising the following steps: mixing and crushing the preparation raw materials to obtain the traditional Chinese medicine composition.

4. Use of the Chinese medicine composition for treating myocardial ischemia according to any one of claims 1 to 3 in the preparation of a medicament for improving cardiac output.

5. Use of the Chinese medicine composition for treating myocardial ischemia according to any one of claims 1 to 3 in preparing a medicament for reducing aortic valve area.

6. Use of the traditional Chinese medicine composition for treating myocardial ischemia according to any one of claims 1 to 3 in the preparation of a medicament for treating myocardial ischemia.

7. Use of the traditional Chinese medicine composition for treating myocardial ischemia according to any one of claims 1 to 3 in preparing a medicament for treating heart valve regurgitation.

8. Use of the traditional Chinese medicine composition for treating myocardial ischemia according to any one of claims 1 to 3 in preparing a medicament for treating ascending aortic aneurysm.

9. The use according to any one of claims 4 to 8, It is characterized in that The dosage forms of the drug include tablets, pills, capsules, granules, granules, and oral liquids; Preferably, the drug further comprises a pharmaceutically acceptable excipient.

10. The use according to claim 9, It is characterized in that The auxiliary materials include any one of excipients, diluents, carriers, flavoring agents, adhesives or fillers, or a combination of at least two of them.

Citation Information

Patent Citations

  • Traditional Chinese medicinal formula for treating myocardial infarction and preparation method

    CN109045149A